Marcy GrahamMarcy Graham

Marcy Graham, VP of IR and corporate comms. for aTyr Pharma, has moved to publicly traded San Diego-based Mirati Therapeutics, in that same title.

Graham handled two major financing and an IPO at aTyr, which went public last May in a $75M public offering.

Graham previously led IR and corporate comms. at Ambit Biosciences through its acquisition by Daichi Sankyo in late 2014. She also did stints at biopharma companies Sequenom and Genoptix.